Antengene Corporation
Latest round
- Series C
Last raised
- Jul 2020
Total raised
- $238M
Investors
- 12
About Antengene Corporation
Founded in 2016 and based in Shanghai, China, Antengene Corporation Limited operates as a biopharmaceutical company that develops medicines for cancer treatment. Antengene Corporation has five clinical-stage products under research and development for relapsed/refractory multiple myeloma, lymphomas, solid tumors and multiple cancer types.
Who invested in Antengene Corporation
12 investors across 3 rounds
See all investors in Antengene Corporation
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Antengene Corporation
Who invested in Antengene Corporation?
Antengene Corporation has 12 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Antengene Corporation raised?
Antengene Corporation has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Antengene Corporation last raise money?
Antengene Corporation's most recent round on record is a Series C, in Jul 2020.
What does Antengene Corporation do?
Founded in 2016 and based in Shanghai, China, Antengene Corporation Limited operates as a biopharmaceutical company that develops medicines for cancer treatment.
Where is Antengene Corporation headquartered?
Antengene Corporation is headquartered in Shanghai, China.
Which VCs invest in companies like Antengene Corporation?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at Antengene Corporation's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like Antengene Corporation? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.